Absorption and metabolism of lanatoside C. II. Fate after oral administration.
The absorption, metabolism, and excretion of lanatoside C were studied in hospitalized subjects following oral administration of the tritiated drug. Previous reports of an unusual double peak in plasma levels of radioactivity were confirmed. Fifty plasma samples taken from 31 patients showed that an average of 74% of the radioactive material was digoxin and its metabolites. There was little or no lanatoside C in 36 of the 50 samples of plasma. Similar results were obtained for urine radioactivity. The results confirm that lanatoside C is converted to "digoxin" in the gut prior to absorption as previously proposed by us. "Digoxin" refers to digoxin and its breakdown products, namely, digoxigenin and its mono- and didigitoxosides. According to these proposals, the conversion to "digoxin"  takes place partly as a result of acid hydrolysis in the gut and partly by the action of bacteria in the intestine. The effects of concurrent administration of antacid therapy, anticholinergic therapy, and food on the fate of oral lanatoside C were separately studied. There were no significant differences between groups with respect to the amount of radioactive material absorbed or excreted, but there were marked qualitative differences in the plasma profiles. There was a statistically significant increase in the time to the first peak in plasma radioactivity in patients concurrently receiving either food or anticholinergic therapy and there was a significant decrease in the relative height of the first peak in patients treated concurrently with antacid.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001682:Biological Availability; D001702:Biopharmaceutics; D004064:Digestive System / Q000378:metabolism; D004077:Digoxin / Q000378:metabolism; D005260:Female; D006207:Half-Life; D006801:Humans; D007799:Lanatosides / Q000378:metabolism*; D008297:Male; D008875:Middle Aged
D007799:Lanatosides; D004077:Digoxin